1. Blundel, T.L. (1996) Structure-based drug design. Nature 384S, 23–26.
2. Stoll, V., Qin, W., Stewart, K.D., Jakob, C., Park, C., Walter, K., Simmer, R.L., Helfrich, R., Bussiere, D., Kao, J., Kempf, D., Sham, H.L., and Norbeck, D.W. (2002) X-ray crystallographic structure of ABT-378 (lopinavir) bound to HIV-1 protease. Bioorg. Med. Chem. 10, 2803–2806.
3. Varghese, J.N. (1999) Development of neuraminidase inhibitors as anti-influenza virus drugs. Drug Dev. Res. 46, 176–196.
4. http://www.mpibp-frankfurt.mpg.de/michel/public/memprotstruct.html
5. Civelli, O., Nothacker, H.P., Saito, Y., Wang, Z., Lin, S.H., and Reinsheid, R.K. (2001) Novel neurotransmitters as natural ligands of orphan G protein-coupled receptors. Trends Neurosci. 24, 230–237.